More on NUVB

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+17.6% Growth)
- Ratings (8.5 Score)
- Holders

Upcoming Events

- Earnings (8/6/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Nuvation Bio (NY:NUVB)
Delayed: 5.76 +0.20 (3.60%)
Prev. Close $5.56  
Open$5.64 
52 Wk High$ 
52 Wk Low$ 
Day High$5.88 
Day Low$5.61 
P/E N/A  
EPS$ 
Volume4,154,957 

Friends, Peers and Foes (?): ONC, ACET, ACRV, ARVN, AZN (more...)

Jun 11, 2026 08:03 PM Form 4 Nuvation Bio Inc. For: Jun 09 Filed by: Mashal Robert
Jun 10, 2026 05:19 AM Nuvation Bio (NUVB) Reiterated at Market Outperform by Citizens Amid Acquisition by GSK
Jun 9, 2026 11:32 AM RBC Capital: 'On balance we think readthroughs from the GSK acquisition of NUVB's key competitor are positive'
May 27, 2026 04:16 PM Form 8-K Nuvation Bio Inc. For: May 21
May 27, 2026 04:05 PM Nuvation Bio to Present at the Jefferies Global Healthcare Conference
May 27, 2026 08:00 AM Nuvation Bio to present quality-of-life data for IBTROZI at ASCO 2026
May 27, 2026 08:00 AM Nuvation Bio to Present New Quality-of-Life Data for IBTROZI® (Taletrectinib) in Patients with ROS1-Positive Non-Small Cell Lung Cancer at ASCO 2026 Annual Meeting
May 26, 2026 08:08 PM Form 4 Nuvation Bio Inc. For: May 21 Filed by: VERNON W ANTHONY
May 26, 2026 08:07 PM Form 4 Nuvation Bio Inc. For: May 21 Filed by: Mashal Robert
May 26, 2026 08:06 PM Form 4 Nuvation Bio Inc. For: May 21 Filed by: FALBERG KATHRYN E
View All Articles

Entities mentioned with NUVB

View All Entities